trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Cystadenocarcinoma, Mucinous D018282 1 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Papillary, Follicular D018265 1 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Rhabdomyosarcoma, Alveolar D018232 2 associated lipids
Fibromatosis, Aggressive D018222 2 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Sachs LM et al. An essential role of histone deacetylases in postembryonic organ transformations in Xenopus laevis. 2001 Int. J. Mol. Med. pmid:11712071
Lefevre P et al. Identification of factors mediating the developmental regulation of the early acting -3.9 kb chicken lysozyme enhancer element. 2001 Nucleic Acids Res. pmid:11713304
Sekita N et al. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines. 2001 Jpn. J. Cancer Res. pmid:11572762
Yin L et al. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. 2001 J. Biol. Chem. pmid:11572859
Leng SL et al. Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo. 2001 Carcinogenesis pmid:11577001
Yang X et al. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. 2001 Cancer Res. pmid:11585728
Plant KE et al. Intergenic transcription in the human beta-globin gene cluster. 2001 Mol. Cell. Biol. pmid:11533239
Chen Lf W et al. Duration of nuclear NF-kappaB action regulated by reversible acetylation. 2001 Science pmid:11533489
Sawa H et al. Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad. 2001 Brain Tumor Pathol pmid:11908866
Benjamin D and Jost JP Reversal of methylation-mediated repression with short-chain fatty acids: evidence for an additional mechanism to histone deacetylation. 2001 Nucleic Acids Res. pmid:11522830
Xu D et al. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11274400
Seth KA and Majzoub JA Repressor element silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) can act as an enhancer as well as a repressor of corticotropin-releasing hormone gene transcription. 2001 J. Biol. Chem. pmid:11278361
Matsuda E et al. Targeting of Krüppel-associated box-containing zinc finger proteins to centromeric heterochromatin. Implication for the gene silencing mechanisms. 2001 J. Biol. Chem. pmid:11278721
Kim MS et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. 2001 Nat. Med. pmid:11283670
Vigushin DM et al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. 2001 Clin. Cancer Res. pmid:11309348
Magdinier F and Wolffe AP Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11309512
Grande A et al. A functionally active RARalpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines. 2001 Cell Death Differ. pmid:11313705
Wu Y et al. Negative regulation of bcl-2 expression by p53 in hematopoietic cells. 2001 Oncogene pmid:11313951
Rashid SF et al. Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. 2001 Oncogene pmid:11313934
Osborne A et al. Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation. 2001 Mol. Cell. Biol. pmid:11533238
Chen C et al. Evidence that silencing of the HPRT promoter by DNA methylation is mediated by critical CpG sites. 2001 J. Biol. Chem. pmid:11013250
Ullerås E et al. Inhibition of histone deacetylase activity causes cell type-specific induction of the PDGF-B promoter only in the absence of activation by its enhancer. 2001 Exp. Cell Res. pmid:11640883
Arthur JL et al. Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro. 2001 J. Virol. pmid:11264377
Furumai R et al. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11134513
Johnson CA et al. Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis. 2001 J. Biol. Chem. pmid:11136718
Griswold MD et al. Mechanisms involved in the homologous down-regulation of transcription of the follicle-stimulating hormone receptor gene in Sertoli cells. 2001 Mol. Cell. Endocrinol. pmid:11223181
Chang YC et al. Cooperation of E2F-p130 and Sp1-pRb complexes in repression of the Chinese hamster dhfr gene. 2001 Mol. Cell. Biol. pmid:11158299
Newell-Price J et al. The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression. 2001 Mol. Endocrinol. pmid:11158338
Kamitani H et al. Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma. 2001 Carcinogenesis pmid:11159758
Rombouts K et al. Trichostatin A, lead compound for development of antifibrogenic drugs. 2001 Jul-Sep Acta Gastroenterol. Belg. pmid:11680040
McGuinness MC et al. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. 2001 Sep-Oct Mol. Genet. Metab. pmid:11592822
López-Solache I et al. Regulation of uncoupling protein-2 mRNA in L6 myotubules: II: Thyroid hormone amplifies stimulation of uncoupling protein-2 gene by thiazolidinediones and other peroxisome proliferator-activated receptor ligands in L6 myotubules: evidence for a priming effect. 2002 Endocrine pmid:12588052
Chen T et al. Histone acetylation is involved in hsp70 gene transcription regulation in Drosophila melanogaster. 2002 Arch. Biochem. Biophys. pmid:12464268
Rombouts K et al. Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor. 2002 J. Hepatol. pmid:12445420
Guo WH et al. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. 2002 Oncogene pmid:12447699
Marin-Husstege M et al. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. 2002 J. Neurosci. pmid:12451133
Wang ZM et al. Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines. 2002 Ai Zheng pmid:12508652
Duharcourt S and Yao MC Role of histone deacetylation in developmentally programmed DNA rearrangements in Tetrahymena thermophila. 2002 Eukaryotic Cell pmid:12455963
Strait KA et al. Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin A are associated with changes in p21, Rb, and Id proteins. 2002 Mol. Cancer Ther. pmid:12479699
Blagosklonny MV et al. Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity. 2002 Mol. Cancer Ther. pmid:12481415
Drewell RA et al. Methylation-dependent silencing at the H19 imprinting control region by MeCP2. 2002 Nucleic Acids Res. pmid:11861904
Murphy JC et al. Control of cytomegalovirus lytic gene expression by histone acetylation. 2002 EMBO J. pmid:11867539
Kim JY et al. Probing lysine acetylation with a modification-specific marker ion using high-performance liquid chromatography/electrospray-mass spectrometry with collision-induced dissociation. 2002 Anal. Chem. pmid:12433071
Gregory RI et al. Inhibition of histone deacetylases alters allelic chromatin conformation at the imprinted U2af1-rs1 locus in mouse embryonic stem cells. 2002 J. Biol. Chem. pmid:11821379
Elaut G et al. Major phase I biotransformation pathways of Trichostatin a in rat hepatocytes and in rat and human liver microsomes. 2002 Drug Metab. Dispos. pmid:12433798
Lim Y et al. Trichostatin A-induced detransformation correlates with decreased focal adhesion kinase phosphorylation at tyrosine 861 in ras-transformed fibroblasts. 2002 J. Biol. Chem. pmid:11821402
Yáñez RJ and Porter AC A chromosomal position effect on gene targeting in human cells. 2002 Nucleic Acids Res. pmid:12433992
Takechi S et al. Chicken HDAC2 down-regulates IgM light chain gene promoter activity. 2002 Biochem. Biophys. Res. Commun. pmid:12437980
Roddie PH et al. Primary acute myeloid leukaemia blasts resistant to cytokine-induced differentiation to dendritic-like leukaemia cells can be forced to differentiate by the addition of bryostatin-1. 2002 Leukemia pmid:11840267
Taniura S et al. Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells. 2002 J. Biol. Chem. pmid:11877441
Heltweg B and Jung M A microplate reader-based nonisotopic histone deacetylase activity assay. 2002 Anal. Biochem. pmid:11878795
Kamitani H et al. Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced. 2002 Neuro-oncology pmid:11916500
Kishikawa S et al. Roles of histone acetylation in the Dnmt1 gene expression. 2002 Nucleic Acids Res. Suppl. pmid:12903179
Ginjala V et al. Multiple cis elements within the Igf2/H19 insulator domain organize a distance-dependent silencer. A cautionary note. 2002 J. Biol. Chem. pmid:11777900
Cabral AL et al. Regulation of the cellular prion protein gene expression depends on chromatin conformation. 2002 J. Biol. Chem. pmid:11739375
Park SH et al. Transcriptional regulation of the transforming growth factor beta type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells. 2002 J. Biol. Chem. pmid:11744689
Suenaga M et al. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. 2002 Int. J. Cancer pmid:11807787
Gurova KV et al. Expression of prostate specific antigen (PSA) is negatively regulated by p53. 2002 Oncogene pmid:11791186
Maeda Y et al. Repression of hepatocyte nuclear factor 4alpha tumor suppressor p53: involvement of the ligand-binding domain and histone deacetylase activity. 2002 Mol. Endocrinol. pmid:11818510
Singal R et al. Methylation of promoter proximal-transcribed sequences of an embryonic globin gene inhibits transcription in primary erythroid cells and promotes formation of a cell type-specific methyl cytosine binding complex. 2002 J. Biol. Chem. pmid:11684679
Bordonaro M et al. Cell type- and promoter-dependent modulation of the Wnt signaling pathway by sodium butyrate. 2002 Int. J. Cancer pmid:11774242
Fang D et al. Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF. 2002 Nucleic Acids Res. pmid:12136092
Zschocke J et al. Estrogen receptor alpha-mediated silencing of caveolin gene expression in neuronal cells. 2002 J. Biol. Chem. pmid:12138116
Yu Z et al. Histone deacetylases augment cytokine induction of the iNOS gene. 2002 J. Am. Soc. Nephrol. pmid:12138131
Li J et al. Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. 2002 Mol. Cell. Biol. pmid:12138181
Aapola U et al. Imprinting regulator DNMT3L is a transcriptional repressor associated with histone deacetylase activity. 2002 Nucleic Acids Res. pmid:12177302
Chang TH and Szabo E Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung. 2002 Clin. Cancer Res. pmid:11948134
Ventura A et al. The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter. 2002 J. Biol. Chem. pmid:11948181
Gradoville L et al. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle. 2002 J. Virol. pmid:11991990
Uesato S et al. Novel histone deacetylase inhibitors: N-hydroxycarboxamides possessing a terminal bicyclic aryl group. 2002 Bioorg. Med. Chem. Lett. pmid:11992774
Nambiar MP et al. Effect of trichostatin A on human T cells resembles signaling abnormalities in T cells of patients with systemic lupus erythematosus: a new mechanism for TCR zeta chain deficiency and abnormal signaling. 2002 J. Cell. Biochem. pmid:11967985
Fu M et al. Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. 2002 Mol. Cell. Biol. pmid:11971970
Sirchia SM et al. Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. 2002 Cancer Res. pmid:11980632
Milutinovic S et al. Proliferating cell nuclear antigen associates with histone deacetylase activity, integrating DNA replication and chromatin modification. 2002 J. Biol. Chem. pmid:11929879
Williams RS et al. A common mechanism of action for three mood-stabilizing drugs. 2002 Nature pmid:12015604
Veilleux S and Boissonneault G Dynamics of reporter gene stimulation by HMG box proteins. 2002 DNA Cell Biol. pmid:12015897
Huang HC et al. Geldanamycin inhibits trichostatin A-induced cell death and histone H4 hyperacetylation in COS-7 cells. 2002 Life Sci. pmid:12002521
Chiocca S et al. Histone deacetylase 1 inactivation by an adenovirus early gene product. 2002 Curr. Biol. pmid:11937030
Curradi M et al. Molecular mechanisms of gene silencing mediated by DNA methylation. 2002 Mol. Cell. Biol. pmid:11940673
Ito K et al. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12070353
Katula KS et al. Cell cycle specific changes in the human cyclin B1 gene regulatory region as revealed by response to trichostatin A. 2002 Arch. Biochem. Biophys. pmid:12054478
Wang XQ et al. Histone deacetylase inhibition results in decreased macrophage CD9 expression. 2002 Biochem. Biophys. Res. Commun. pmid:12056820
Rahmani M et al. The histone deacetylase inhibitor sodium butyrate interacts synergistically with phorbol myristate acetate (PMA) to induce mitochondrial damage and apoptosis in human myeloid leukemia cells through a tumor necrosis factor-alpha-mediated process. 2002 Exp. Cell Res. pmid:12061815
Woo SH et al. Structurally simple trichostatin A-like straight chain hydroxamates as potent histone deacetylase inhibitors. 2002 J. Med. Chem. pmid:12061890
Chen Y et al. On the epigenetic regulation of the human reelin promoter. 2002 Nucleic Acids Res. pmid:12087179
Zhang Y and Dufau ML Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. 2002 J. Biol. Chem. pmid:12091390
Danbara M et al. DNA methylation dominates transcriptional silencing of Pax5 in terminally differentiated B cell lines. 2002 Mol. Immunol. pmid:12044782
Lin HM et al. Cyclin D1 Is a Ligand-independent Co-repressor for Thyroid Hormone Receptors. 2002 J. Biol. Chem. pmid:12048199
Quivy V et al. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. 2002 J. Virol. pmid:12368351
Smith WL and Edlind TD Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. 2002 Antimicrob. Agents Chemother. pmid:12384361
Harada K et al. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. 2002 Cancer Res. pmid:12384554
Im H et al. Histone deacetylase-dependent establishment and maintenance of broad low-level histone acetylation within a tissue-specific chromatin domain. 2002 Biochemistry pmid:12484752
Zhang J et al. Establishment of transcriptional competence in early and late S phase. 2002 Nature pmid:12432398
Gong XQ and Li L Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation. 2002 J. Biol. Chem. pmid:11809751
Kostyniuk CL et al. The ubiquitous and tissue specific promoters of the human SRC gene are repressed by inhibitors of histone deacetylases. 2002 Oncogene pmid:12214274
Rössig L et al. Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis. 2002 Circ. Res. pmid:12411399
Hall IM et al. Establishment and maintenance of a heterochromatin domain. 2002 Science pmid:12215653
Lynch CA et al. Reactivation of a silenced H19 gene in human rhabdomyosarcoma by demethylation of DNA but not by histone hyperacetylation. 2002 Mol. Cancer pmid:12234381
Bereshchenko OR et al. Acetylation inactivates the transcriptional repressor BCL6. 2002 Nat. Genet. pmid:12402037
Chen Z et al. Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells. 2002 Cancer Lett. pmid:12406558